Human cytomegalovirus resistance to antiviral drugs

被引：168

作者：

Gilbert, C

Boivin, G

机构：

[1] CHUL, CHUQ, Res Ctr Infect Dis, Ste Foy, PQ G1V 4G2, Canada

[2] Univ Laval, Dept Med Biol, Ste Foy, PQ G1K 7P4, Canada

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 03期

关键词：

D O I：

10.1128/AAC.49.3.873-883.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：873 / 883

页数：11

共 142 条

[21] Detection of ganciclovir resistance mutations and quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease [J].

Boivin, G ;

Chou, SW ;

Quirk, MR ;

Erice, A ;

Jordan, MC .

JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (03) :523-528

[22] Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis [J].

Boivin, G ;

Gilbert, C ;

Gaudreau, A ;

Greenfield, I ;

Sudlow, R ;

Roberts, NA .

JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (12) :1598-1602

[23] SYMPTOMATIC CONGENITAL CYTOMEGALOVIRUS-INFECTION - NEONATAL MORBIDITY AND MORTALITY [J].

BOPPANA, SB ;

PASS, RF ;

BRITT, WJ ;

STAGNO, S ;

ALFORD, CA .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (02) :93-99

[24]

Bowen EF, 1999, J MED VIROL, V58, P402, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt

[25]

402::AID-JMV13&gt

[26]

3.0.CO

[27]

2-5

[28] A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products [J].

Buerger, I ;

Reefschlaeger, J ;

Bender, W ;

Eckenberg, P ;

Popp, A ;

Weber, O ;

Graeper, S ;

Klenk, HD ;

Ruebsamen-Waigmann, H ;

Hallenberger, S .

JOURNAL OF VIROLOGY, 2001, 75 (19) :9077-9086

[29] ALPHA-HERPESVIRUSES, BETA-HERPESVIRUSES AND GAMMA-HERPESVIRUSES ENCODE A PUTATIVE PHOSPHOTRANSFERASE [J].

CHEE, MS ;

LAWRENCE, GL ;

BARRELL, BG .

JOURNAL OF GENERAL VIROLOGY, 1989, 70 :1151-1160

[30] In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: Relationship to clinical outcome [J].

Cherrington, JM ;

Fuller, MD ;

Lamy, PD ;

Miner, R ;

Lalezari, JP ;

Nuessle, S ;

Drew, WL .

JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06) :1821-1825

← 1 2 3 4 5 6 7 8 9 10 →